$385M Price Tag for Abbott Labs' Safety Slip Ups The pharmaceutical industry has long faced criticism on issues of safety, efficacy, and corporate accountability.
A recent example is the nearly $385 million settlement between Abbott Laboratories and federal authorities over a bacterial contamination issue at its Michigan plant.
The fine itself is notable, but what's more striking is the behind the scenes maneuvering that led to this outcome.